Human Phenotype Ontology 
Grandparent Node:
expandAbnormality of coagulation (HP:0001928)help
Parent Node:
expandAbnormality of fibrinolysis (HP:0040224)help
..Starting node
..expandReduced euglobulin clot lysis time (HP:0040247)help
Term ID: 40247
Name: Reduced euglobulin clot lysis time
Synonym:
Definition: Abnormally decreased length of time required for an in vitro clot to dissolve in the absence of the normal plasmin inhibitors. This test is a clinical assay used to measure fibrinolysis. The euglobulin fraction of plasma is precipitated and used to form clot by addition of thrombin; after clot forms the rate of clot breakdown (fibrinolysis) can be monitored.
Comments:
Reference: HP:0040247
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandHyperfibrinolysis (HP:0040236) help
..expandProlonged euglobulin clot lysis time (HP:0040243) help
..expandReduced plasminogen activator inhibitor 1 activity (HP:0040248) help
..expandReduced plasminogen activator inhibitor 1 antigen (HP:0040249) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0040247HP:0040247Reduced euglobulin clot lysis time0SERPINF2 CL E G H53459075ORPHA:79Congenital alpha2-antiplasmin deficiencyHP:0040282 - Frequent8


Genes (1) :SERPINF2

Diseases (1) :ORPHA:79
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.